Elite Pharmaceuticals, Inc. (ELTP.OB) Provides Elite Numbers for Third Quarter
Located in Northvale, New Jersey, Elite has earned a stellar name within the pharmaceutical industry due to their development of oral sustained and controlled released products. With a strategy that includes assisting partner companies in the life cycle management of products to improve off-patent drugs and developing generic versions of controlled release drug products, Elite has started to turn heads on Wall Street. Today, Elite Pharmaceuticals released their 3rd quarter 2010 financial results. The company showed that for the 3rd quarter ending December 31, 2009, Elite generated revenues of $917,383, which is an increase of 287% for the comparable period…